J M Catov1,2, M F Muldoon3, S E Reis4,5, R B Ness6, L N Nguyen7, J-M Yamal8, H Hwang8, W T Parks9. 1. Department of Obstetrics, Gynecology and Reproductive Sciences, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA. 2. Department of Epidemiology, Graduate School of Public Health, Pittsburgh, PA, USA. 3. Department of Medicine, University of Pittsburgh, School of Medicine and Hypertension Center, University of Pittsburgh Medical Center Heart and Vascular Institute, Pittsburgh, PA, USA. 4. Office of Clinical Research, Clinical Translational Science Institute, University of Pittsburgh, Pittsburgh, PA, USA. 5. Department of Cardiology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA. 6. Division of Epidemiology and Disease Control, Innovation, The University of Texas School of Public Health, Houston, TX, USA. 7. Department of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA. 8. Department of Biostatistics, The University of Texas Health Science Center at Houston, School of Public Health, Houston, TX, USA. 9. Departments of Pathology and Obstetrics, Gynecology and Reproductive Sciences, University of Pittsburgh School of Medicine and the Magee-Womens Hospital of UPMC, Pittsburgh, PA, USA.
Abstract
OBJECTIVE: Preterm birth (PTB) is associated with excess maternal cardiovascular disease risk. We considered that women with PTB and placental evidence of maternal malperfusion would be particularly affected. DESIGN: Pregnancy cohort study. SETTING: Pittsburgh, PA, USA. POPULATION: Women with PTB (n = 115) and term births (n = 210) evaluated 4-12 years after pregnancy. METHODS: Cardiometabolic risk markers were compared in women with prior PTB versus term births; pre-eclampsia and growth restriction cases were excluded. Placental evidence of maternal vascular malperfusion (vasculopathy, infarct, advanced villous maturation, perivillous fibrin, intervillous fibrin deposition), acute infection/inflammation (chorioamnionitis, funisitis, deciduitus) and villitis of unknown aetiology (chronic inflammation) was used to classify PTBs. MAIN OUTCOME MEASURES: Carotid artery intima-media thickness (IMT), fasting lipids, blood pressure (BP) and inflammatory markers measured after delivery. RESULTS: Women with PTB and malperfusion lesions had higher total cholesterol (+13.5 mg/dl) and systolic BP (+4.0 mmHg) at follow up compared with women with term births, accounting for age, race, pre-pregnancy BMI, and smoking (P < 0.05). Women with PTB and malperfusion accompanied by inflammatory lesions had the most atherogenic profile after pregnancy (cholesterol +18.7, apolipoprotein B + 12.7 mg/dl; all P < 0.05), adjusted for pre-pregnancy features. Carotid IMT was higher in this group (+0.037 cm, P = 0.031) accounting for pre-pregnancy factors; differences were attenuated after adjusting for BP and atherogenic lipids at follow up (+0.027, P = 0.095). CONCLUSION: PTBs with placental malperfusion were associated with an excess maternal cardiometabolic risk burden in the decade after pregnancy. The placenta may offer insight into subtypes of PTB related to maternal cardiovascular disease. TWEETABLE ABSTRACT: Preterm births with placental malperfusion may mark women at higher cardiovascular disease risk.
OBJECTIVE: Preterm birth (PTB) is associated with excess maternal cardiovascular disease risk. We considered that women with PTB and placental evidence of maternal malperfusion would be particularly affected. DESIGN: Pregnancy cohort study. SETTING: Pittsburgh, PA, USA. POPULATION: Women with PTB (n = 115) and term births (n = 210) evaluated 4-12 years after pregnancy. METHODS: Cardiometabolic risk markers were compared in women with prior PTB versus term births; pre-eclampsia and growth restriction cases were excluded. Placental evidence of maternal vascular malperfusion (vasculopathy, infarct, advanced villous maturation, perivillous fibrin, intervillous fibrin deposition), acute infection/inflammation (chorioamnionitis, funisitis, deciduitus) and villitis of unknown aetiology (chronic inflammation) was used to classify PTBs. MAIN OUTCOME MEASURES: Carotid artery intima-media thickness (IMT), fasting lipids, blood pressure (BP) and inflammatory markers measured after delivery. RESULTS: Women with PTB and malperfusion lesions had higher total cholesterol (+13.5 mg/dl) and systolic BP (+4.0 mmHg) at follow up compared with women with term births, accounting for age, race, pre-pregnancy BMI, and smoking (P < 0.05). Women with PTB and malperfusion accompanied by inflammatory lesions had the most atherogenic profile after pregnancy (cholesterol +18.7, apolipoprotein B + 12.7 mg/dl; all P < 0.05), adjusted for pre-pregnancy features. Carotid IMT was higher in this group (+0.037 cm, P = 0.031) accounting for pre-pregnancy factors; differences were attenuated after adjusting for BP and atherogenic lipids at follow up (+0.027, P = 0.095). CONCLUSION: PTBs with placental malperfusion were associated with an excess maternal cardiometabolic risk burden in the decade after pregnancy. The placenta may offer insight into subtypes of PTB related to maternal cardiovascular disease. TWEETABLE ABSTRACT: Preterm births with placental malperfusion may mark women at higher cardiovascular disease risk.
Authors: Raymond W Redline; Theonia Boyd; Valarie Campbell; Scott Hyde; Cynthia Kaplan; T Yee Khong; Heather R Prashner; Brenda L Waters Journal: Pediatr Dev Pathol Date: 2004-03-17
Authors: Cheryl L Robbins; Yalonda Hutchings; Patricia M Dietz; Elena V Kuklina; William M Callaghan Journal: Am J Obstet Gynecol Date: 2013-09-18 Impact factor: 8.661
Authors: Mandy J Schmella; Vanessa Assibey-Mensah; W Tony Parks; James M Roberts; Arun Jeyabalan; Carl A Hubel; Janet M Catov Journal: Placenta Date: 2019-03-01 Impact factor: 3.481
Authors: E H Yeung; A Saha; C Zhu; M H Trinh; S N Hinkle; A Z Pollack; K L Grantz; J L Mills; S L Mumford; C Zhang; S L Robinson; M W Gillman; J Zhang; P Mendola; R Sundaram Journal: Placenta Date: 2021-12-15 Impact factor: 3.481
Authors: Alexander J Layden; Marnie Bertolet; W Tony Parks; James M Roberts; Jennifer J Adibi; Janet M Catov Journal: Am J Obstet Gynecol Date: 2022-03-11 Impact factor: 10.693
Authors: Janet M Catov; Matthew F Muldoon; Robin E Gandley; Judith Brands; Alisse Hauspurg; Carl A Hubel; Marie Tuft; Mandy Schmella; Gong Tang; W Tony Parks Journal: Hypertension Date: 2021-12-09 Impact factor: 9.897
Authors: Jonathon L Hecht; Bradley Quade; Vikram Deshpande; Mari Mino-Kenudson; David T Ting; Niyati Desai; Beata Dygulska; Taryn Heyman; Carolyn Salafia; Dejun Shen; Sara V Bates; Drucilla J Roberts Journal: Mod Pathol Date: 2020-08-02 Impact factor: 8.209